Grey Zones in Urolithiasis Guidelines

Eur Urol Focus. 2017 Feb;3(1):144-146. doi: 10.1016/j.euf.2017.01.013. Epub 2017 Feb 9.
No abstract available

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use
  • Europe
  • Humans
  • Practice Guidelines as Topic*
  • Urolithiasis / diagnosis*
  • Urolithiasis / therapy*
  • Watchful Waiting

Substances

  • Adrenergic alpha-Antagonists